SCHEMBL2324367

SCHEMBL2324367

CCCCOC(=O)N1CCC([C]=O)CC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.56
POLB P06746 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
GAA P10253 1/20 0.44
ATM Q13315 2/20 0.41
THRB P10828 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
HRH2 P25021 1/20 0.40
HRH1 P35367 1/20 0.40
CHRM1 P11229 2/20 0.40
CHRM2 P08172 1/20 0.40
NOS3 P29474 1/20 0.39
NOS2 P35228 1/20 0.39
ALDH1A1 P00352 3/20 0.39
HPGD P15428 1/20 0.39
MMP13 P45452 2/20 0.39
MMP2 P08253 1/20 0.39
MMP3 P08254 1/20 0.39
MMP9 P14780 1/20 0.39
MMP8 P22894 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4441606 0.88 LMNA (0.56) LMNAPOLBSMN1; SMN2GAAATM
SCHEMBL30473383 0.86 LMNA (0.55) LMNAPOLBSMN1; SMN2GAAATM
SCHEMBL4631015 0.85 GAA (0.59) POLBSMN1; SMN2GAAATMTHRB
SCHEMBL7449135 0.83 POLB (0.63) LMNAPOLBSMN1; SMN2GAAATM
SCHEMBL184778 0.82 LMNA (0.61) LMNAPOLBSMN1; SMN2GAAATM
SCHEMBL7339506 0.82 LMNA (0.61) LMNAPOLBSMN1; SMN2GAAATM
SCHEMBL4193322 0.82 LMNA (0.54) LMNAPOLBSMN1; SMN2GAAATM
SCHEMBL9405372 0.81 POLB (0.73) LMNAPOLBSMN1; SMN2GAAATM
SCHEMBL856302 0.81 SMN1; SMN2 (0.59) LMNAPOLBSMN1; SMN2GAAATM
SCHEMBL5156110 0.81 LMNA (0.59) LMNAPOLBSMN1; SMN2GAAATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011094890-A1 PHENYLALANINE DERIVATIVES AND THEIR USE AS NON-PEPTIDE GLP-1 RECEPTOR MODULATORS ARGUSINA INC. (US) 2011-08-11 WO disclosed